The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Sodium Iodide I 131 Diagnostic
Sodium Iodide I 131 · SODIUM IODIDE I-131 100 mCi/1 · Capsule · Oral · Jubilant DraxImage Inc., dba Jubilant Radiopharma
NDC 65174-0461-05 · 5 CAPSULE in 1 VIAL · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- NDA021305
- TE code
- AA
- Approval date
- Jan 24, 2003
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
- Class III · TerminatedMar 11, 2016Jubilant Draximage Inc — Labeling: Label Error on Declared Strength
Manufacturers of Sodium Iodide I 131 (Capsule)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Jubilant DraxImage Inc., dba Jubilant Radiopharma | SODIUM IODIDE I-131 100 mCi/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Sodium Iodide I 131 Diagnostic — NDC 65174-0461-05," retrieved September 3, 2026, https://drugdashboards.com/drug/65174046105.
Free to cite with attribution — see how the data is put together.